Recently, through phase separation-based phenotypic screening, Jingjing Xie et al. identified a potential AR inhibitor, ET516, which selectively disrupts AR condensates and inhibits tumor growth in cells harboring resistance mutations in AR 84. The gene discussed is AR; the disease is neoplasm.